Showing results (451-460 of 476) with videos related to

Sort By:
Pageof 48
Microbiome|May 30, 2020
Correction to: Genetic and metabolic links between the murine microbiome and memoryJian-Hua Mao, Young-Mo Kim, Yan-Xia Zhou, et al.
Cancer Research Communications|July 14, 2023
Remodeling of Stromal Immune Microenvironment by Urolithin A Improves Survival with Immune Checkpoint Blockade in Pancreatic CancerSiddharth Mehra, Vanessa T Garrido, Austin R Dosch, et al.
JAMA|June 11, 2014
Hydrolyzed infant formula and early β-cell autoimmunity: a randomized clinical trialMikael Knip, Hans K Åkerblom, Dorothy Becker, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 9, 2013
Effects of dietary phosphate restriction and phosphate binders on FGF23 levels in CKDTamara Isakova, Allison Barchi-Chung, Gwen Enfield, et al.
Diseases of the Colon and Rectum|August 26, 2025
Brave New World: Analysis of Early Clinical Experience with Molecular Sequencing in the Treatment of Rectal CancerJared T Yee, Ahmed A Eltahir, Oluseye K Oduyale, et al.
Nature Communications|December 17, 2021
Intraperitoneal microbial contamination drives post-surgical peritoneal adhesions by mesothelial EGFR-signalingJoel Zindel, Jonas Mittner, Julia Bayer, et al.
Cancer Research|January 29, 2024
Tumor Cell-Intrinsic p38 MAPK Signaling Promotes IL1α-Mediated Stromal Inflammation and Therapeutic Resistance in Pancreatic CancerSamara P Singh, Austin R Dosch, Siddharth Mehra, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|September 13, 2022
Urolithin A attenuates severity of chronic pancreatitis associated with continued alcohol intake by inhibiting PI3K/AKT/mTOR signalingSiddharth Mehra, Supriya Srinivasan, Samara Singh, et al.
Diabetes|August 29, 2006
Analysis of T-cell assays to measure autoimmune responses in subjects with type 1 diabetes: results of a blinded controlled studyVicki Seyfert-Margolis, Trang D Gisler, Adam L Asare, et al.
Molecular Cancer Therapeutics|November 9, 2018
Urolithin A, a Novel Natural Compound to Target PI3K/AKT/mTOR Pathway in Pancreatic CancerTulasigeri M Totiger, Supriya Srinivasan, Venkatakrishna R Jala, et al.
Pageof 48